morphinans and Diabetic-Neuropathies

morphinans has been researched along with Diabetic-Neuropathies* in 1 studies

Other Studies

1 other study(ies) available for morphinans and Diabetic-Neuropathies

Article	Year
The effect of sinomenine in diabetic neuropathic pain mediated by the P2X Purinergic signalling, 2017, Volume: 13, Issue:2 Type 2 diabetes mellitus (T2DM) accounts for more than 90% of all cases of diabetes mellitus (DM). Diabetic neuropathic pain (DNP) is a common complication of T2DM. Sinomenine is a natural bioactive component extracted from the Sinomenium acutum and has anti-inflammatory effects. The aim of our study was to investigate the effects of sinomenine on DNP mediated by the P2X Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia, Spinal; HEK293 Cells; Humans; Hyperalgesia; Male; Morphinans; Pain Threshold; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3	2017

Article

Year

The effect of sinomenine in diabetic neuropathic pain mediated by the P2X

Purinergic signalling, 2017, Volume: 13, Issue:2

Type 2 diabetes mellitus (T2DM) accounts for more than 90% of all cases of diabetes mellitus (DM). Diabetic neuropathic pain (DNP) is a common complication of T2DM. Sinomenine is a natural bioactive component extracted from the Sinomenium acutum and has anti-inflammatory effects. The aim of our study was to investigate the effects of sinomenine on DNP mediated by the P2X

Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia, Spinal; HEK293 Cells; Humans; Hyperalgesia; Male; Morphinans; Pain Threshold; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3

2017